Sonja Zweegman

36PUBLICATIONS
201CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyTumour immunologyNanomedicineMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Aug 19, 2026
Daratumumab plus bortezomib, lenalidomide, and dexamethasone in transplant-deferred newly diagnosed multiple myeloma: Frailty subgroup analysis of CEPHEUS.

|Aug 13, 2026
Clinical outcomes of newly diagnosed myeloma patients with SLIM criteria : a subgroup analysis of the CASSIOPEIA study.

|Jul 09, 2026
The rapidly evolving BCMA landscape in multiple myeloma.

|Jun 03, 2026
Daratumumab in transplant-ineligible or -deferred newly diagnosed multiple myeloma: minimal residual disease in CEPHEUS.

|May 05, 2026
Infections in patients receiving daratumumab for newly diagnosed multiple myeloma: a pooled analysis of MAIA and ALCYONE.

|Mar 27, 2026
FDG-PET medullary total tumor volume highlights high-risk patients with newly diagnosed multiple myeloma in CASSIOPEIA trial.

Bastien Jamet, Shamimeh Ahrari, Sonja Zweegman

Pageof 6

Frequent Collaborators

10 joint publications

Pieter Sonneveld

8 joint publications

Niels W C J van de Donk

6 joint publications

Tuna Mutis

6 joint publications

Aurore Perrot